All Stocks
healthcare

BSX — Boston Scientific Corporation

Conviction45
Congress 90d6
Insider 90d0
Markets8
Lobbying10
Contracts1
CountryUS

BSX

Boston Scientific Corporation

healthcare
45thin · 1 src Bearish1 source agree
🏛 Congress

Congressional trades

Last 90 days
4 buy2 sell2 legislators
  • sell Gilbert Cisneros$1K–$15K · Jun 5, 2026
  • buy Gilbert Cisneros$1K–$15K · Jun 5, 2026
  • sell John Boozman$1K–$15K · Jun 4, 2026
  • buy Gilbert Cisneros$1K–$15K · May 29, 2026
  • buy Gilbert Cisneros$1K–$15K · May 19, 2026
  • buy Gilbert Cisneros$1K–$15K · May 11, 2026

Prediction markets

Live odds

Lobbying filings

Last 2 years
  • BOSTON SCIENTIFIC CORPORATION$642K · 2026 first_quarter
    ENVHCRTAXTRDVET
  • FAEGRE DRINKER BIDDLE & REATH LLP$20K · 2026 first_quarter
    BUDHCRMMM
  • HOGAN LOVELLS US LLP$10K · 2026 first_quarter
    BUDSPO
  • CASSIDY & ASSOCIATES, INC.$50K · 2026 first_quarter
    BUD
  • LIBERTY PARTNERS GROUP, LLC · 2026 first_quarter
    MMM
  • BROWNSTEIN HYATT FARBER SCHRECK, LLP$50K · 2026 first_quarter
    ENG
  • BRICK STREET STRATEGY$20K · 2026 first_quarter
    VET
  • LEWIS-BURKE ASSOCIATES, LLC$10K · 2026 first_quarter
    BUDDEF
  • MUSEUM OF SCIENCE, BOSTON · 2026 first_quarter
    BUDEDUSCI
  • BUTERA, ISRAEL & BECKER PLLC$20K · 2026 first_quarter
    BAN

Country exposure

Domicile · not revenue geography

Approximated from company domicile — not revenue-by-geography.This panel maps the ticker to a single country using the company's registered domicile, a static lookup. It does not reflect where the company actually earns revenue or carries operational exposure (e.g. a US-domiciled chipmaker may have most of its real exposure in Taiwan or China).

🇺🇸 United States59/100
Posture: neutralView United States

Insider activity

No insider transactions filed in the last 90 days.

Federal contracts

$150.8M · 0% defense
  • Department of Health and Human Services$150.8M · Jun 1, 2022
3485b22